UbiB is classified as a probable ubiquinone biosynthesis protein that plays a key role in the oxygen-dependent pathway for ubiquinone production . The protein has been identified in multiple bacterial species, including various strains of Escherichia coli, Salmonella enterica, and Chromobacterium violaceum . Functionally, UbiB demonstrates ATPase activity and is categorized as a probable protein kinase (EC 2.7) .
The significance of UbiB lies in its contribution to cellular bioenergetics through ubiquinone biosynthesis. Ubiquinone, also known as coenzyme Q, is a lipid-soluble electron carrier that functions as a critical component of the electron transport chain in bacterial respiration . The ability to produce recombinant UbiB provides researchers with valuable tools to study ubiquinone biosynthesis mechanisms and their implications for bacterial metabolism and adaptation.
UbiB is characterized as a protein comprised of 546 amino acids in length in several bacterial species including Escherichia coli and Salmonella enterica . The protein exists in various bacterial strains including E. coli O9:H4 (strain HS) and E. coli O127:H6 (strain E2348/69 / EPEC), suggesting its conservation across different lineages . This conservation indicates the fundamental importance of UbiB in bacterial metabolism, particularly in energy production pathways.
Ubiquinone is a lipid-soluble molecule with a crucial role in cellular bioenergetics . It functions as an electron carrier in the electron transport chain, facilitating aerobic respiration in many bacterial species. The biosynthesis of ubiquinone is particularly important for bacteria that encounter environments with varying oxygen levels, as it allows them to adapt their respiratory metabolism accordingly .
The complete ubiquinone biosynthetic pathway requires a series of reactions to modify the aromatic ring of the precursor, 4-hydroxybenzoic acid (4-HB), including one prenylation, one decarboxylation, three hydroxylation, and three methylation reactions . The complexity of this pathway highlights the sophisticated biochemical machinery that bacteria employ to synthesize this essential component of their respiratory chain.
In the context of the ubiquinone biosynthetic pathway, UbiB serves as an accessory factor with demonstrated ATPase activity . While the exact biochemical mechanism of UbiB's action remains to be fully elucidated, its classification as a probable protein kinase (EC 2.7) suggests it may be involved in phosphorylation events that regulate the biosynthetic process .
UbiB is specifically involved in the oxygen-dependent pathway for ubiquinone biosynthesis . This pathway requires molecular oxygen (O₂) as a substrate for certain reactions, particularly hydroxylation steps. UbiB's specific contribution to this pathway involves its ATPase activity, which likely supports the energetic requirements of certain biosynthetic reactions .
Recent research has revealed the existence of two distinct pathways for ubiquinone biosynthesis in bacteria: an oxygen-dependent pathway and an oxygen-independent pathway . This dual pathway system represents an important adaptive feature in proteobacteria, allowing them to synthesize ubiquinone across the entire range of environmental oxygen levels.
Table 2: Comparison of Oxygen-Dependent and Oxygen-Independent Ubiquinone Biosynthesis Pathways
In contrast to the UbiB-associated oxygen-dependent pathway, an oxygen-independent pathway for ubiquinone biosynthesis has been identified that relies on three proteins: UbiT (YhbT), UbiU (YhbU), and UbiV (YhbV) . This alternative pathway allows bacteria to synthesize ubiquinone even in anoxic environments, providing metabolic flexibility.
UbiT contains an SCP2 lipid-binding domain and likely functions as an accessory factor, while UbiU and UbiV form a heterodimer that acts as a novel class of oxygen-independent hydroxylases, each binding a 4Fe-4S cluster essential for activity . The identification of this oxygen-independent pathway highlights the remarkable metabolic adaptability of proteobacteria, enabling them to maintain essential respiratory functions across diverse environmental conditions.
The presence of both oxygen-dependent and oxygen-independent pathways for ubiquinone biosynthesis represents an important adaptive feature in proteobacteria. This metabolic plasticity enables these organisms to colonize environments with large oxygen gradients or fluctuating oxygen levels . Such adaptations have been linked to antibiotic resistance, virulence, and the capacity to thrive in complex ecosystems like the microbiota .
Recombinant UbiB protein can be produced using various expression systems. According to the available research, these systems include Escherichia coli, yeast, baculovirus, or mammalian cell expression platforms . The choice of expression system depends on factors such as desired yield, post-translational modifications, and the intended application of the recombinant protein.
Table 3: Expression Systems for Recombinant UbiB Production
Several recombinant forms of UbiB are available for research purposes, including:
Recombinant E. coli UbiB Protein (aa 1-546) from strain E2348/69 / EPEC
Recombinant Chromobacterium violaceum Probable ubiquinone biosynthesis protein UbiB (partial)
These recombinant proteins serve as valuable tools for studying the structure, function, and biochemical properties of UbiB in controlled laboratory settings. It is important to note that these products are explicitly designated for research purposes only and cannot be used directly on humans or animals .
Recombinant UbiB enables several important research applications:
Structural studies to investigate the three-dimensional organization and functional domains of this important biosynthetic enzyme
Functional assays to characterize its enzymatic activities, including its reported ATPase function and potential protein kinase activity
Pathway analysis to understand the regulation and efficiency of the oxygen-dependent ubiquinone biosynthetic pathway
Comparative studies examining UbiB function across different bacterial species
UbiB has been extensively studied in E. coli, a gram-negative, facultatively anaerobic, rod-shaped bacterium that serves as a model organism in microbiology and biotechnology . In E. coli, UbiB exists as a 546-amino acid protein involved in the oxygen-dependent pathway for ubiquinone biosynthesis .
Different strains of E. coli express UbiB, including strain HS (O9:H4) and strain E2348/69 (O127:H6, EPEC) . The protein's conservation across these strains suggests its fundamental importance in E. coli metabolism and energy production.
UbiB has also been identified in Salmonella enterica subsp. enterica serovar Dublin strain CT_02021853 as a 546-amino acid protein . The computed structure model available for Salmonella UbiB (UniProtKB: B5FNW8) provides insights into its three-dimensional organization and potential functional domains .
Additionally, UbiB has been identified in Chromobacterium violaceum, where it is similarly described as a probable ubiquinone biosynthesis protein . The presence of UbiB across these diverse bacterial species demonstrates the conservation of the ubiquinone biosynthetic pathway and highlights its evolutionary importance.
The discovery of dual pathways for ubiquinone biosynthesis—oxygen-dependent and oxygen-independent—raises questions about how bacteria regulate these alternative routes . Future research could explore the conditions that favor one pathway over the other and the mechanisms that control pathway switching in response to environmental oxygen levels.
Such investigations could provide insights into bacterial adaptation to varying environmental conditions, with potential implications for understanding bacterial survival in diverse ecological niches, including host environments during infection.
While the recombinant UbiB proteins described are explicitly limited to research applications , further investigation of ubiquinone biosynthesis could potentially reveal new therapeutic targets. The link between metabolic adaptability, antibiotic resistance, and virulence suggests that modulating ubiquinone biosynthesis might offer novel approaches to combating bacterial infections .
Additionally, understanding UbiB function and ubiquinone biosynthesis may have applications in biotechnology, potentially contributing to the development of engineered bacterial strains with enhanced or modified respiratory capabilities for industrial processes.
KEGG: ecc:c4784
STRING: 199310.c4784
UbiB is a probable ubiquinone biosynthesis protein involved in the production of ubiquinone (coenzyme Q), an essential component of the electron transport chain. While specific information about UbiB is limited in the current literature, it likely functions as part of the cellular machinery responsible for synthesizing ubiquinone. Research suggests that ubiquinone biosynthesis in bacteria can occur through both O₂-dependent and O₂-independent pathways, with various Ubi proteins playing crucial roles in these processes . To investigate UbiB's specific function, researchers typically employ genetic approaches such as gene knockout studies, complementation assays, and protein-protein interaction studies to determine its position in the biosynthetic pathway.
UbiB likely functions in concert with other ubiquinone biosynthesis proteins. Recent research has characterized novel proteins such as UbiT, UbiU, and UbiV that form part of an O₂-independent pathway for ubiquinone biosynthesis . UbiT contains an SCP2 lipid-binding domain and likely serves as an accessory factor, while UbiU and UbiV function as O₂-independent hydroxylases that form a heterodimer complex with 4Fe-4S clusters essential for activity . To determine UbiB's relationship with these proteins, researchers should conduct co-immunoprecipitation studies, yeast two-hybrid screens, or proximity-based labeling experiments. Comparative genomic analysis across bacterial species can also reveal evolutionary relationships and functional associations between these proteins.
While specific structural data for UbiB is not directly available in the provided sources, recombinant protein expression systems similar to those used for UBE4B could be employed to produce UbiB for structural analysis . Typically, recombinant proteins are expressed with tags (such as His-tags) to facilitate purification and characterization . For structural studies of UbiB, researchers should consider expression in eukaryotic systems like baculovirus-infected insect cells, which often provide better protein folding for complex proteins . X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, or cryo-electron microscopy could then be employed to elucidate UbiB's three-dimensional structure, active sites, and potential binding domains.
For in vivo studies of UbiB function, researchers should consider implementing single-subject experimental designs (SSEDs) that allow for rigorous assessment of cause-and-effect relationships . A withdrawal design (ABA/ABAB) could be particularly effective, where condition A represents wild-type expression and condition B represents UbiB deletion or modification . This approach allows researchers to observe how cellular function changes with the manipulation of UbiB and confirms causality by demonstrating reversibility . The conservative dual-criterion (CDC) method can be applied to analyze results, requiring a predetermined number of data points above both level and trend lines to conclude that systematic change has occurred . For example, in a 10-data point treatment phase, at least 8 points should fall above both criteria lines to indicate a significant effect .
To address potential functional redundancy between UbiB and other biosynthesis proteins, researchers should implement a multiple-baseline design across conditions . This approach involves creating multiple genetic constructs with different combinations of gene knockouts or modifications. Data analysis should follow the conservative dual-criterion (CDC) method to determine whether systematic changes occur when manipulating UbiB alone versus in combination with other genes . For each comparison in an ABAB design, researchers can break the analysis into three separate AB designs (initial AB, BA, second AB) and analyze each separately to determine if systematic changes occur across phases . This approach helps to isolate UbiB's specific contribution to ubiquinone biosynthesis even in the presence of potential redundant pathways.
When investigating UbiB's role across different oxygen conditions, researchers must implement careful controls. Since ubiquinone biosynthesis can occur through both O₂-dependent and O₂-independent pathways , experiments should be designed to measure UbiB activity across a range of oxygen concentrations. Critical controls include:
| Control Type | Purpose | Implementation |
|---|---|---|
| Positive controls | Verify assay functionality | Include known O₂-dependent proteins (e.g., UbiF) |
| Negative controls | Establish baseline | Assay with inactive protein variants |
| System controls | Validate oxygen conditions | Use established O₂-sensitive and resistant processes |
| Genetic controls | Isolate UbiB function | Compare wild-type, knockout, and complemented strains |
Researchers should also consider measuring activity of known O₂-independent proteins like UbiU-UbiV as comparators, since these form a heterodimer with 4Fe-4S clusters that are essential for their hydroxylase activity in anaerobic conditions .
For real-time monitoring of UbiB-mediated reactions, researchers should consider combining spectroscopic and chromatographic techniques. While no specific method for UbiB is mentioned in the provided sources, approaches similar to those used for studying UBE4B activity could be adapted . For monitoring ubiquitination reactions catalyzed by E3 ligases like UBE4B, in vitro assays typically employ concentrations of 100-500 nM depending on experimental conditions and substrate . For UbiB, researchers might develop similar in vitro assays with appropriate substrates and cofactors, monitoring activity through:
Fluorescence resonance energy transfer (FRET) with labeled substrates
High-performance liquid chromatography (HPLC) to quantify reaction products
Mass spectrometry to identify chemical modifications
Oxygen consumption measurements using oxygen-sensitive probes
These approaches would allow researchers to observe UbiB activity under various conditions and determine kinetic parameters such as Km and Vmax.
Many ubiquinone biosynthesis proteins are membrane-associated, which presents unique challenges for biochemical characterization. To address these challenges, researchers should consider:
Using detergent-based extraction methods optimized for membrane proteins
Employing nanodiscs or liposomes to maintain a lipid environment
Utilizing membrane mimetics for structural studies
Implementing in situ approaches like fluorescence recovery after photobleaching (FRAP)
For expression of membrane proteins, baculovirus-infected insect cell systems similar to those used for UBE4B may provide better results than bacterial expression systems . Additionally, carrier-free protein preparations can be valuable for certain applications where adding carriers like BSA might interfere with downstream analyses .
Computational methods can provide valuable insights into UbiB function ahead of experimental validation. Researchers should consider:
Sequence-based analyses including multiple sequence alignments and phylogenetic profiling to identify conserved domains and co-evolving proteins
Structural prediction using homology modeling or ab initio approaches
Molecular dynamics simulations to predict protein-substrate interactions
Genome context analyses to identify functionally related genes
These computational predictions can guide experimental design, particularly for determining potential binding partners, substrates, or functional domains within UbiB. Integration of computational and experimental approaches offers the most comprehensive strategy for characterizing this probable ubiquinone biosynthesis protein.
For quantitative analysis of UbiB function in different oxygen conditions, a utility-based Bayesian optimal interval (U-BOIN) approach could be adapted from clinical trial designs to optimize experimental conditions . This would involve:
Developing a utility function that measures the trade-off between different experimental parameters
Jointly modeling multiple outcome variables using a multinomial-Dirichlet model
Updating posterior estimates after each experimental iteration
Using these estimates to direct subsequent experimental conditions
This approach enables researchers to efficiently explore the parameter space while accumulating data on UbiB activity under various conditions .
When facing conflicting results across different model systems, researchers should implement a systematic approach to resolve discrepancies:
Evaluate the experimental design quality using established criteria (like those in Table 1 from source )
Conduct visual analysis supplemented with formal methods like CDC to determine if systematic effects are present
Assess whether experimental effects have been sufficiently replicated within each study to rule out extraneous variables
Consider contextual factors that might explain differences between model systems
When studying UbiB's role in ubiquinone biosynthesis, researchers may encounter delayed effects where changes in measurements don't immediately follow experimental manipulations. This latency can call into question whether the independent variable (UbiB manipulation) is truly responsible for observed changes . To address this challenge, researchers should:
Ensure experimental effects are replicated within the study to rule out extraneous variables
Implement designs that accommodate delayed responses, such as extended baseline and intervention phases
Consider adapting methods from clinical trial design that handle delayed outcomes by leveraging short-term endpoints to predict delayed outcomes
For example, researchers might measure immediate changes in gene expression or protein localization as predictors of later changes in ubiquinone levels. The utility-based Bayesian optimal interval (U-BOIN) design could be particularly useful, as it consists of two seamless stages: an initial exploration stage followed by a more focused investigation based on preliminary data .
Research on UbiB and other ubiquinone biosynthesis proteins has significant implications for understanding ubiquinone deficiency disorders. Since ubiquinone plays a crucial role in cellular bioenergetics, dysfunction in its biosynthesis pathway can lead to mitochondrial diseases . Researchers investigating these connections should:
Establish clear genotype-phenotype correlations between UbiB variants and clinical presentations
Develop cellular and animal models with UbiB mutations that recapitulate disease phenotypes
Design intervention studies that target specific steps in the affected pathway
These studies would benefit from single-subject experimental designs (SSEDs) to track individual responses to interventions, particularly when patient populations are small . The withdrawal design (ABAB) would be especially valuable for testing potential treatments, though ethical considerations regarding withdrawing effective interventions must be carefully considered .
To advance understanding of UbiB structure-function relationships, researchers should consider integrating cutting-edge technologies:
Cryo-electron microscopy to visualize UbiB alone and in complex with interaction partners
Hydrogen-deuterium exchange mass spectrometry to map dynamic regions and binding interfaces
Single-molecule techniques to observe conformational changes during catalysis
CRISPR-based approaches for precise genomic editing to study UbiB variants
Expression systems similar to those used for UBE4B could be adapted, potentially using baculovirus-infected insect cells to produce properly folded recombinant UbiB . Adding affinity tags (like the His6 tag used for UBE4B) would facilitate purification while maintaining protein function . For certain applications, carrier-free protein preparations would be valuable to avoid interference from carrier proteins in downstream analyses .
The discovery of both O₂-dependent and O₂-independent pathways for ubiquinone biosynthesis suggests that bacteria have evolved sophisticated mechanisms to maintain energy metabolism across different oxygen environments . UbiB's function may vary across bacterial species depending on their oxygen adaptations. To investigate these differences, researchers should:
Conduct comparative genomic analyses across alpha-, beta-, and gammaproteobacterial clades
Perform functional complementation studies across species
Measure UbiB activity in microaerobic and anaerobic conditions
Investigate the relationship between UbiB and O₂-independent proteins like UbiU-UbiV
This research has particular relevance for understanding pathogens that must navigate host environments with varying oxygen levels . The ability to synthesize ubiquinone across the entire O₂ range represents an important metabolic adaptation that may contribute to bacterial survival in complex ecosystems like the human microbiota .